Home / 2019 / June / 01

Daily Archives: June 1, 2019

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania

 Lugano, Switzerland, June 1, 2019 – Helsinn, the Swiss pharmaceutical group focused on building quality cancer care products, in conjunction with the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO), today announces Allison Barz Leahy, MD, University of Pennsylvania, as the recipient of the Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care for 2019.

Conquer Cancer’s Young Investigator Award (YIA) funds physicians who are in the final years of training to aid their transition from a fellowship program to a faculty appointment. The YIA is a one-year $50,000 grant that aims to promote quality research in clinical oncology.

The recipient of this endowed YIA, Dr. Allison B. Leahy, received her medical degree from SUNY Upstate College of Medicine. She completed her Pediatric Residency and Pediatric Hematology/Oncology Fellowship at the Children’s Hospital of Philadelphia (CHOP). Dr. Leahy is a recent alumna of the Pediatric Hospital Epidemiology and Outcomes Research Training program managed by the Center for Pediatric Clinical Effectiveness at CHOP and is currently finishing her thesis work for her Master of Science in Clinical Epidemiology from the University of Pennsylvania. Dr. Leahy’s clinical interests include investigating the benefits and barriers of using patient-reported symptom monitoring for children with cancer in an attempt to examine the impact of this type of monitoring on the quality of life, hospitalization rate and illness severity in childhood cancer. Dr. Leahy’s YIA project is entitled Symptom monitoring using patient-reported outcomes in newly diagnosed pediatric cancer patients.

Established in 2016, the endowed YIA honors the life of Anna Braglia, the wife of Helsinn Group Founder and Chairman Gabriele Braglia and mother of Helsinn Group Vice Chairman and CEO Riccardo Braglia, who passed away in 2015. Helsinn endowed this award, which is part of Conquer Cancer’s ’s Grants and Award’s Program, to encourage more aspiring physicians to move into all areas of oncology by supporting them as they move from academia into research.

 Riccardo Braglia, Helsinn Group Vice Chairman and CEO, commented:Dr. Allison Leahy is an exceptional candidate for this award. Her work on patient-reported outcomes in childhood cancer has the potential to dramatically improve the quality of life for cancer care in children. At Helsinn, we strive to improve the standard of living for individuals with cancer. Dr. Leahy’s work aligns with our goals and visions to put the patient at the heart of the approach cancer care and we are delighted to be able to support her invaluable work. We wish Dr. Leahy the best with her project”  

Dr. Allison B. Leahy, said: ” I am greatly honored to receive the Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care. This award will provide invaluable resources for the investigation of the use of patient-reported symptom monitoring in pediatric oncology care. Determining how best to incorporate the child’s voice into their medical care is essential – and we are hopeful that this work lay the necessary groundwork to enhance communication with the treating team, increase patient and family engagement in care, and ultimately lead to better clinical outcomes for children undergoing treatment for cancer.”

About the Helsinn Group

Helsinn is a privately-owned pharmaceutical group with an extensive portfolio of marketed cancer care products and a robust drug development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity and quality. The Group works across pharmaceuticals, biotechnology, medical devices and nutritional supplements and has expertise in research, development, manufacture and the commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology. In 2016, Helsinn created the Helsinn Investment Fund to support early-stage investment opportunities in areas of unmet patient need. The company is headquartered in Lugano, Switzerland, with operating subsidiaries in Switzerland, Ireland and the U.S., a representative office in China as well as a product presence in approximately 190 countries globally.

 About Conquer Cancer

Conquer Cancer®, the ASCO Foundation, funds research into every facet of cancer to

benefit every patient, everywhere. In 1964, seven oncologists created the American

Society of Clinical Oncology (ASCO), now a global network of nearly 45,000 cancer

professionals. As ASCO’s foundation, Conquer Cancer helps turn science into a sigh

of relief for patients around the world by supporting groundbreaking research and

education across cancer’s full continuum.

 For more information, visit CONQUER.ORG.

 For more information:

Helsinn Group Media Contact:

Paola Bonvicini
Group Head of Communication
Lugano, Switzerland
Tel: +41 (0) 91 985 21 21
Email: Info-hhc@helsinn.com

For more information, please visit www.helsinn.com and follow us on Twitter, LinkedIn and Vimeo

McDonalds Malaysia reintroduces spicy Korean burger for ‘Discover the World’ campaign

KUALA LUMPUR, June 1 (Bernama) — McDonald’s Malaysia is kicking off it’s annual ‘Discover the World’ campaign by bringing back the much loved Spicy Korean Burger, this time around with a new chicken version along with the original beef version.

In a statement today, vice president and chief marketing officer McDonald’s Malaysia Melati Abdul Hai said McDonald’s was excited to kick-off this year’s campaign by reintroducing the Spicy Korean Burger which had received an overwhelming response when first launched in 2017.

As with our previous ‘Discover the World’ campaigns, McDonald’s is once again pleased to offer an exciting line-up of special edition burgers that features distinctive flavours from selected countries all over the world, right here in Malaysia.

It has now become a menu item customers look forward to because of its delicious Korean taste that appeals to Malaysians, she said.

For customers who want to complement their meals with something refreshing, the Green Tea McFlurry is also making a comeback to the McDonald’s dessert menu together with the brand new Chocolate Pie, which comes with a delicious chocolate filling in a crispy chocolate-covered shell.

Available starting today, the Spicy Korean Burger comes in a set together with French fries and either a Fanta McFreeze or Coke at priced from RM15.99.

Source: BERNAMA (News Agency)

Debt Management Committee holds first meeting to discuss RM1.1 trilion debt

KUALA LUMPUR, June 1 (Bernama) — The newly set-up Debt Management Committee (DMC) chaired by the Minister of Finance has convened its first meeting yesterday, to discuss the government’s overall debt and liabilities of RM1.1 trillion or 75.4 per cent of the gross domestic product as at end-2018.

In a statement today, the Ministry of Finance (MoF) said this was partly due to a RM54.2 billion rise in direct government debt to RM741.0 billion from RM686.8 billion in the previous year.

The rise in debt was used to finance the fiscal deficit, especially for expenditure arising from public-private partnership lease commitments and off-budget spending that were previously not transparently included in the budget, it said.

Total committed government guarantees that are paid by the government, to finance ongoing public transport projects also rose.

The increase in committed government guarantees was not caused by any new infrastructure projects but instead was due to the need to finance existing ones, said MoF.

The three transport projects are the East Coast Rail Link, Mass Rapid Transit and Light Rail Transit.

MoF said the committee would identify measures to reduce the level, as well as improve the management of government debt and liabilities.

These measures will include evaluation of high-cost projects and identification of government-guaranteed debt to be restructured, of which, this measure is needed because the debt service charge for various financial obligations is preventing the government from funding other more productive programmes and projects, it added.

The statement also reiterated that for the time being, the issuance cost of some government-guaranteed debt were similar to those issued by domestic corporate entities with AAA credit rating.

However, the issuance cost of any debt backed by government guarantee should be approximately equivalent to government papers like the Malaysian Government Securities (MGS), it said.

As of May 31, 2019, the coupon rate for 10-year MGS stood at 3.78 per cent per annum, which was among the lowest rates enjoyed by the government in recent history.

Additionally, the committee will review all acts, procedures and legal requirements relating to the issuance of direct government debt, government guarantees and other government commitments.

Source: BERNAMA (News Agency)